NCT02293980 · Interventional trial
A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001)
Overall registry status Active not recruiting
Phase 1
Conditions Clear Cell Renal Cell Carcinoma, Kidney Cancer, RCC, Renal Cell Carcinoma, ccRCC
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory